Darlene Deptula-Hicks

Darlene Deptula-Hicks is a seasoned financial executive with extensive experience in the biotechnology sector. Currently serving as a Senior Strategic Financial Advisor at Grey Wolf Therapeutics and a Board Member for Avacta, Darlene also holds board positions at Aerami Therapeutics and Abcuro, Inc., where leadership in audit committees is a prominent role. Previous experience includes serving as Chief Financial Officer at F-star Therapeutics and T2 Biosystems, and holding directorial roles at Giner Life Sciences and Xenetic Biosciences. Darlene's educational background includes an MBA from Rivier University and a BS in Accounting from Southern New Hampshire University, complemented by advanced business education from The Tuck School of Business at Dartmouth.